Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Matei

Showing results (141-150 of 187) with videos related to

Pageof 19
Sort By:
Biomedical Reports|September 30, 2024
Nephrotic syndrome as a possible indicator of colonic cancer: A case reportRoxana Surugiu, Ștefănița Bianca Vintilescu, Raluca Elena Sandu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
Alkaline reflux esophagitis in patients with total gastrectomy and Roux en Y esojejunostomyDaniela Matei, Razvan Dadu, Raluca Prundus, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|January 13, 2022
Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?Anca Maria Amzolini, Mircea Cătălin Forţofoiu, Anca Barău Abu-Alhija, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2024
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian CancerYinu Wang, Xiaolei Situ, Horacio Cardenas, et al.
JCI Insight|February 18, 2025
Complement activation at the interface between adipocytes and cancer cells drives tumor progressionAndres Valdivia, Ana Maria Isac, Horacio Cardenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trialDaniela Matei, Michael W Sill, Heather A Lankes, et al.
Cancer|October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm studyWilliam P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 24, 2024
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox BalanceYinu Wang, Andrea E Calvert, Horacio Cardenas, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|October 23, 2023
Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemicOana Maria Ică, George Mitroi, Simona Laura Ianoşi, et al.
The Journal of Clinical Investigation|October 1, 2025
SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancerAlexander J Duval, Fidan Seker-Polat, Magdalena Rogozinska, et al.
Pageof 19

Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
Biomedical Reports|September 30, 2024
Nephrotic syndrome as a possible indicator of colonic cancer: A case reportRoxana Surugiu, Ștefănița Bianca Vintilescu, Raluca Elena Sandu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
Alkaline reflux esophagitis in patients with total gastrectomy and Roux en Y esojejunostomyDaniela Matei, Razvan Dadu, Raluca Prundus, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|January 13, 2022
Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?Anca Maria Amzolini, Mircea Cătălin Forţofoiu, Anca Barău Abu-Alhija, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2024
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian CancerYinu Wang, Xiaolei Situ, Horacio Cardenas, et al.
JCI Insight|February 18, 2025
Complement activation at the interface between adipocytes and cancer cells drives tumor progressionAndres Valdivia, Ana Maria Isac, Horacio Cardenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trialDaniela Matei, Michael W Sill, Heather A Lankes, et al.
Cancer|October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm studyWilliam P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 24, 2024
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox BalanceYinu Wang, Andrea E Calvert, Horacio Cardenas, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|October 23, 2023
Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemicOana Maria Ică, George Mitroi, Simona Laura Ianoşi, et al.
The Journal of Clinical Investigation|October 1, 2025
SOX9 drives a stem-like transcriptional state and platinum resistance in high-grade serous ovarian cancerAlexander J Duval, Fidan Seker-Polat, Magdalena Rogozinska, et al.
Pageof 19